BE
BEAT.US Heartbeam Inc
- Market cap
- USD 25.0M
- P/E
- -
- P/B
- 2.81x
- ROE
- -261.0%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is BEAT.US undervalued?
Graham numberThe Graham number of Heartbeam Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Heartbeam Inc fundamental analysis
No fundamental analysis for Heartbeam Inc yet.
Heartbeam Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Heartbeam Inc
HeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing electrocardiogram solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility. The company develops HeartBeam System, a cable-free and ambulatory 12L ECG that captures the heart's electrical signals from three dimensions for high-fidelity data collection and advanced diagnostics for arrhythmia assessment which consists of credit card…
Full company profileHeartbeam Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Heartbeam Inc annual financial statements
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 208M | 287M | 399M | 439M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - |
| Gross Profit | 129M | 172M | 250M | 274M | - | - | - | - | -7.00K | -40.0K | - |
| Operating Income | 35.9M | 37.4M | 84.0M | -294K | -788K | -2.29M | -13.0M | -15.3M | -19.9M | -21.1M | -17.7M |
| EBITDA | 30.0M | 24.2M | 92.0M | 42.7M | -788K | -2.26M | -12.9M | 675K | -19.4M | -21.0M | -16.9M |
| Net Income | 53.4M | -16.0M | 42.8M | -778K | -1.35M | -4.43M | -12.8M | -14.6M | -19.4M | -21.0M | -17.0M |
| EPS | 1.75 | -0.53 | 1.20 | -0.10 | -0.17 | -0.57 | -1.57 | -0.72 | -0.73 | -0.62 | -0.30 |
| Balance Sheet | |||||||||||
| Total Assets | 199M | 525M | 587M | 7.00K | 51.0K | 14.0M | 4.04M | 17.1M | 3.28M | 5.84M | 7.87M |
| Total Liabilities | 60.1M | 275M | 276M | 3.73M | 4.84M | 588K | 1.67M | 1.19M | 1.62M | 3.24M | 1.36M |
| Shareholders' Equity | 139M | 251M | 310M | -3.73M | -4.79M | 13.4M | 2.37M | 15.9M | 1.65M | 2.60M | 6.51M |
| Cash & Short-term Investments | 23.1M | 36.0M | 80.9M | 5.00K | 24.0K | 13.2M | 3.59M | 16.2M | 2.38M | 4.38M | 6.07M |
| Total Debt | 25.2M | 199M | 199M | 3.42M | 4.30M | - | - | - | - | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | 38.9M | 23.8M | 72.7M | -218K | -600K | -3.23M | -9.95M | -12.1M | -14.5M | -14.0M | -12.7M |
| Capital Expenditure | 10.9M | 13.7M | 24.6M | 30.7M | 0.00 | 0.00 | 0.00 | 256K | 201K | 600K | 752K |
| Free Cash Flow | 28.0M | 10.1M | 48.1M | -218K | -600K | -3.23M | -9.95M | -12.3M | -14.7M | -14.6M | -13.5M |
| Ratios | |||||||||||
| ROE | 38.5% | -6.4% | 13.8% | - | - | -33.0% | -540.3% | -91.9% | -1,175.8% | -807.3% | -261.0% |
| ROA | 26.9% | -3.0% | 7.3% | -11,114.3% | -2,643.1% | -31.6% | -317.6% | -85.5% | -593.7% | -359.7% | -215.9% |
| Net Profit Margin | 25.6% | -5.6% | 10.7% | -0.2% | - | - | - | - | - | - | - |
| Debt to Equity | 0.18x | 0.80x | 0.64x | - | - | - | - | - | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Heartbeam Inc dividends
Heartbeam Inc has not paid dividends in the last 9 fiscal years.
Who owns Heartbeam Inc
- Insiders 19.57%
- Institutions 14.52%
- Public & others 65.91%
- Shares outstanding 63.3M
- Free float 43.7M
Top funds holding BEAT.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Vanguard MStar Total Stk Mkt Idx Invest | 1.45M | 2.57% | 0.00% | Sep 2026 |
| Abante Quant Value FI | 257K | 0.46% | 0.00% | Aug 2026 |
| Fidelity Extended Market Index | 246K | 0.44% | -0.38% | Sep 2026 |
| iShares Micro-Cap ETF | 141K | 0.25% | 0.00% | Oct 2026 |
| Fidelity Series Total Market Index | 73.7K | 0.13% | 0.00% | Sep 2026 |
| Fidelity Total Market Index | 70.2K | 0.12% | 0.00% | Sep 2026 |
| Vanguard Balanced Index Inv | 33.0K | 0.06% | 0.00% | Sep 2026 |
| Vanguard U.S. Eq Idx £ Acc | 13.3K | 0.02% | 0.00% | Sep 2026 |
| 1290 VT Micro Cap K | 10.5K | 0.02% | 0.00% | Sep 2026 |
| Fidelity Nasdaq Composite Index | 2.66K | 0.00% | -93.91% | Aug 2026 |
Top institutions holding BEAT.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Vanguard Capital Management, LLC | 2.14M | 3.79% | +78.45% | Jun 2026 |
| BlackRock Inc | 988K | 1.75% | +9.96% | Jun 2026 |
| Corsair Capital Management LLC | 913K | 1.62% | 0.00% | Jun 2026 |
| Bleichroeder LP | 625K | 1.11% | 0.00% | Jun 2026 |
| Geode Capital Management, LLC | 479K | 0.85% | +27.09% | Jun 2026 |
| Smith, Salley & Associates, LLC | 368K | 0.65% | 0.00% | Jun 2026 |
| UBS Group AG | 299K | 0.53% | -10.82% | Jun 2026 |
| Vanguard Fiduciary Trust Co | 275K | 0.49% | +83.14% | Jun 2026 |
| Sigma Planning Corp | 248K | 0.44% | +86.87% | Jun 2026 |
| Beacon Pointe Advisors, LLC | 247K | 0.44% | -0.16% | Jun 2026 |
| Comprehensive Portfolio Management, LLC | 208K | 0.37% | 0.00% | Jun 2026 |
| O'Shaughnessy Asset Management LLC | 208K | 0.37% | 0.00% | Jun 2026 |
| KESTRA PRIVATE WEALTH SERVICES, LLC | 173K | 0.31% | -0.29% | Jun 2026 |
| State Street Corp | 125K | 0.22% | 0.00% | Jun 2026 |
| Northern Trust Corp | 101K | 0.18% | +73.87% | Jun 2026 |
| Spectrum Asset Management Inc | 100K | 0.18% | +6.36% | Jun 2026 |
| Cannon Financial Strategists, INC. | 92.6K | 0.16% | +27.28% | Sep 2026 |
| Morgan Stanley - Brokerage Accounts | 57.0K | 0.10% | -2.65% | Jun 2026 |
| XTX Topco Ltd | 54.3K | 0.10% | +355.47% | Jun 2026 |
| Stifel Financial Corp | 51.0K | 0.09% | 0.00% | Jun 2026 |
Heartbeam Inc company profile
- Company name
- Heartbeam Inc
- Ticker
- BEAT.US
- Exchange
- USA Stocks
- Listed since
- Nov 11, 2021
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 16
- Fiscal year end
- December
- Address
- 2118 Walsh Avenue, Santa Clara, CA, United States, 95050
- Phone
- 408 899 4443
- Website
- heartbeam.com
About Heartbeam Inc
HeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing electrocardiogram solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility. The company develops HeartBeam System, a cable-free and ambulatory 12L ECG that captures the heart's electrical signals from three dimensions for high-fidelity data collection and advanced diagnostics for arrhythmia assessment which consists of credit card sized 3D ECG recording device, a patient application, a physician portal, and powerful cloud-based algorithms. HeartBeam, Inc. was incorporated in 2015 and is based in Santa Clara, California.
Heartbeam Inc management
7- Mr. Richard M. FerrariExecutive Chairman · born 1954
- Dr. Branislav Vajdic Ph.D.Founder, President & Director · born 1955
- Mr. Timothy CruickshankChief Financial Officer · born 1982
- Mr. Kenneth PersenChief System Development Officer
- Dr. Peter J. Fitzgerald FACC, M.D., Ph.D.Member of Scientific Advisory Board & Chief Medical Advisor · born 1957
- Dr. Lance Myers Ph.D.Chief Artificial Intelligence Scientist
- Mr. Bryan HumbargerChief Commercial Officer